SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
Loading market information…
HKSE · 6086.HK · HKD
Stock price, earnings
Quote as of Oct 30, 2026, 06:01 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Fangzhou Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Fangzhou Inc.’s next earnings report is currently expected on Mar 19, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fangzhou Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
CN¥48.46-CN¥0.16 (-0.33%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.39% below the high.
HK$50.80+HK$0.15 (+0.3%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.25% below the high.
HK$38.24+HK$2.26 (+6.28%)
JD Health International Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.67% below the high.
HK$2.83+HK$0.08 (+2.72%)
Alibaba Health Information Technology Limited’s quoted price sits in the lower half of its reported 52-week range, 64.22% below the high.
HK$3.09-HK$0.37 (-10.58%)
160 Health International Ltd.’s quoted price sits in the lower half of its reported 52-week range, 98.05% below the high.
HK$1.39-HK$0.06 (-4.14%)
Sipai Health Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.13% below the high.
HK$0.40HK$0.00 (0.0%)
ClouDr Group Limited’s quoted price sits in the lower half of its reported 52-week range, 68.75% below the high.
